My reviews
5.0
Where I see patients (1)
Selected research
-
Organ responses with daratumumab therapy in previously treated AL amyloidosis.
Blood advances
-
Cutaneous plasmablastic plasmacytoma.
Blood
-
Therapy-related myeloid neoplasms after treatment for plasma-cell disorders.
Best practice & research. Clinical haematology
Clinical trials
Pembrolizumab for the Treatment of Relapsed or Refractory Multiple Myeloma After Anti-BCMA CAR-...
The International Myeloma Working Group (IMWG) uniform response criteria will be used to assess disease response and progression. The response rate is defined as the proportion of patients achieving a partial response (PR), very g...
Recruiting
Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refract...
ORR is defined as stringent complete response (sCR) + complete response (CR) + very good partial response + partial response (PR) as best response using International Myeloma Working Group (IMWG) Uniform Response Criteria for all ...
Recruiting
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421